Cargando…

Inhalation Devices

Detalles Bibliográficos
Autores principales:	Moroni-Zentgraf, Petra, Usmani, Omar S., Halpin, David M. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167575/ https://www.ncbi.nlm.nih.gov/pubmed/30319720 http://dx.doi.org/10.1155/2018/5642074

Ejemplares similares

Correct inhalation technique is critical in achieving good asthma control
por: Lavorini, Federico, et al.
Publicado: (2013)

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
por: Halpin, David M.G., et al.
Publicado: (2020)

Inhaler devices and their challenges - Helping patients use inhalers
por: Chawhan, Ashwini, et al.
Publicado: (2023)

Spacer devices for inhaled therapy: why use them, and how?
por: Vincken, Walter, et al.
Publicado: (2018)

In Vitro Determination of Respimat(®) Dose Delivery in Children: An Evaluation Based on Inhalation Flow Profiles and Mouth–Throat Models
por: Bickmann, Deborah, et al.
Publicado: (2016)

A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old
por: Kamin, Wolfgang, et al.
Publicado: (2015)

Choosing the right inhaler for your asthma or COPD patient
por: Usmani, Omar S
Publicado: (2019)

A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids
por: Vogelberg, Christian, et al.
Publicado: (2015)

Erratum to: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids
por: Vogelberg, Christian, et al.
Publicado: (2015)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

Is It Possible to Achieve Better Asthma Control by Using the Same Inhaler Device?
por: Shin, Yoo Seob, et al.
Publicado: (2012)

Is there room for further innovation in inhaled therapy for airways disease?
por: Biddiscombe, Martyn F., et al.
Publicado: (2018)

Effective respiratory management of asthma and COPD and the environmental impacts of inhalers
por: Usmani, Omar S., et al.
Publicado: (2023)

Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

O05 - Once-daily tiotropium in adolescents with symptomatic asthma despite inhaled corticosteroid treatment: a dose-ranging study
por: Vogelberg, Christian, et al.
Publicado: (2014)

Erratum to: Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?
por: Singh, Dave, et al.
Publicado: (2020)

Calling Time on Spirometry: Unlocking the Silent Zone in Acute Rejection after Lung Transplantation
por: Usmani, Omar S.
Publicado: (2020)

Inhalers, inhalers everywhere, but not a proper puff
por: van Zyl-Smit, Richard, et al.
Publicado: (2019)

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)
por: Dekhuijzen, Pieter Nicolaas Richard, et al.
Publicado: (2016)

Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV(1)
por: Halpin, David M. G., et al.
Publicado: (2019)

Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A., et al.
Publicado: (2023)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Let research leave you breathless, not physical exercise!
por: Bonini, Matteo, et al.
Publicado: (2018)

Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis
por: Halpin, David M. G., et al.
Publicado: (2020)

Patient perceptions of the re-usable Respimat(®) Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study
por: Dreher, Michael, et al.
Publicado: (2021)

On the Inhalation of Sulphuric Ether
Publicado: (1847)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
por: Bloom, Chloe I, et al.
Publicado: (2020)

Biophysical model to predict lung delivery from a dual bronchodilator dry-powder inhaler
por: Dolovich, Myrna B., et al.
Publicado: (2019)

The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients
por: Darbà, Josep, et al.
Publicado: (2015)

Editorial for Special Issue “Leaf Senescence” in Plants
por: Zentgraf, Ulrike, et al.
Publicado: (2021)

Inhale the future, exhale the past
por: Kumar, Ashish
Publicado: (2017)

Before and beyond Inhaled Corticosteroids
por: Vazquez Guillamet, Rodrigo
Publicado: (2020)

Death from Inhalation of Ether
Publicado: (1873)

Chronic Obstructive Pulmonary Disease and Work: Is It Time to Stop?
por: Halpin, David
Publicado: (2019)

Anæsthetic Inhalation
Publicado: (1870)

Chloroform Inhalations
Publicado: (1853)

A New Inhaler for All Anæsthetics
Publicado: (1866)

Dangers from Protracted Inhalation of Ether
Publicado: (1888)

Inhaled Corticosteroids and Bronchiectasis: Friend or Foe?
por: Martinez-Garcia, Miguel Angel
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0tj1lqg1mqp5qjgp09el40m91k